Retrospective analysis of hypofractionated stereotactic radiotherapy for tumors larger than 2 cm.

Yutaro Koide(Nagoya University Hospital), Takeshi Kodaira(Aichi Cancer Center), Natsuo Tomita(Aichi Cancer Center), Sou Adachi(Aichi Medical University Hospital), Hiroshi Tanaka(Aichi Cancer Center), Hiroyuki Tachibana(Aichi Cancer Center)

PubMed

August 1, 2019

10.18999/nagjms.81.3.397

Cited by 12

Related Papers

Impact of concurrent antibody–drug conjugates and radiotherapy on symptomatic radiation necrosis in breast cancer patients with brain metastases: a multicenter retrospective study

|Journal of Neuro-Oncology|2024|34

Clinical results of definitive chemoradiotherapy for cervical esophageal cancer: Comparison of failure pattern and toxicities between intensity‐modulated radiotherapy and 3‐dimensional conformal radiotherapy

|Head & Neck|2017|32

Role of high-dose salvage radiotherapy for oligometastases of the localised abdominal/pelvic lymph nodes: a retrospective study

|BMC Cancer|2020|27

Risk of second primary malignancies after definitive treatment for esophageal cancer: A competing risk analysis

|Cancer Medicine|2019|23

A predictive model for pain response following radiotherapy for treatment of spinal metastases

|Scientific Reports|2021|23